Literature DB >> 35213012

Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles.

Paula Milán-Rois1, Ciro Rodriguez-Diaz1, Milagros Castellanos1, Álvaro Somoza2.   

Abstract

Gold nanoparticles (AuNPs) can be used as carriers for biomolecules or drugs in cell culture and animal models. Particularly, AuNPs ease their internalization into the cell and prevent their degradation. In addition, engineered AuNPs can be employed as sensors of a variety of biomarkers, where the electronic and optical properties of the AuNPs are exploited for a convenient, easy, and fast read out. However, in all these applications, a key step requires the conjugation of the different molecules to the nanoparticles. The most common approach exploits the great affinity of sulfur for gold. Herein, we summarize the methods used by our group for the conjugation of different molecules with AuNPs. The procedure is easy and takes around 2 days, where the reagents are slowly added, following an incubation at room temperature to ensure the complete conjugation. Finally, the unbound material is removed by centrifugation.
© 2022. The Author(s).

Entities:  

Keywords:  Conjugation; Drug delivery; Functionalization; Gold nanoparticles; Metal nanoparticles; Nanomedicine; Oligonucleotides; Sensors; Spherical nucleic acid

Mesh:

Substances:

Year:  2022        PMID: 35213012     DOI: 10.1007/978-1-0716-2010-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Spherical nucleic acids.

Authors:  Joshua I Cutler; Evelyn Auyeung; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2012-01-09       Impact factor: 15.419

Review 2.  New Developments in Liposomal Drug Delivery.

Authors:  Bhushan S Pattni; Vladimir V Chupin; Vladimir P Torchilin
Journal:  Chem Rev       Date:  2015-05-26       Impact factor: 60.622

3.  Viral nanoparticles in drug delivery and imaging.

Authors:  Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2013-01-07       Impact factor: 4.939

Review 4.  Application of gold nanoparticles in biomedical and drug delivery.

Authors:  Hadis Daraee; Ali Eatemadi; Elham Abbasi; Sedigheh Fekri Aval; Mohammad Kouhi; Abolfazl Akbarzadeh
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-09-17       Impact factor: 5.678

Review 5.  Mesoporous silica nanoparticles in nanomedicine applications.

Authors:  Miguel Manzano; María Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2018-05-08       Impact factor: 3.896

Review 6.  Inorganic nanoparticles in diagnosis and treatment of breast cancer.

Authors:  Cristina Núñez; Sergio Vázquez Estévez; María Del Pilar Chantada
Journal:  J Biol Inorg Chem       Date:  2018-02-16       Impact factor: 3.358

Review 7.  Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer.

Authors:  Shubhangi Mahajan; Abhimanyu Patharkar; Kaushik Kuche; Rahul Maheshwari; Pran Kishore Deb; Kiran Kalia; Rakesh K Tekade
Journal:  Int J Pharm       Date:  2018-07-08       Impact factor: 5.875

Review 8.  Delivery of oligonucleotide-based therapeutics: challenges and opportunities.

Authors:  Suzan M Hammond; Annemieke Aartsma-Rus; Sandra Alves; Sven E Borgos; Ronald A M Buijsen; Rob W J Collin; Giuseppina Covello; Michela A Denti; Lourdes R Desviat; Lucía Echevarría; Camilla Foged; Gisela Gaina; Alejandro Garanto; Aurelie T Goyenvalle; Magdalena Guzowska; Irina Holodnuka; David R Jones; Sabine Krause; Taavi Lehto; Marisol Montolio; Willeke Van Roon-Mom; Virginia Arechavala-Gomeza
Journal:  EMBO Mol Med       Date:  2021-04-06       Impact factor: 12.137

Review 9.  Delivery is key: lessons learnt from developing splice-switching antisense therapies.

Authors:  Caroline Godfrey; Lourdes R Desviat; Bård Smedsrød; France Piétri-Rouxel; Michela A Denti; Petra Disterer; Stéphanie Lorain; Gisela Nogales-Gadea; Valentina Sardone; Rayan Anwar; Samir El Andaloussi; Taavi Lehto; Bernard Khoo; Camilla Brolin; Willeke Mc van Roon-Mom; Aurélie Goyenvalle; Annemieke Aartsma-Rus; Virginia Arechavala-Gomeza
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

Review 10.  Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.

Authors:  Yi Gou; Dandan Miao; Min Zhou; Lijuan Wang; Hongyu Zhou; Gaoxing Su
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.